OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Issue Highlights	76
Binaural hearing impairment in patients with schizophrenia: A multicenter study	62
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	60
Psychopathology trajectories and relapse in first episode schizophrenia with assured long-acting injectable adherence over 24 months	55
The effectiveness of adjunctive cariprazine for treatment of negative symptoms: A systematic review of randomised controlled trials	55
Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia	54
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	52
Issue Highlights	49
Insomnia and aggression in stable schizophrenic patients: The mediating role of quality of life	47
Home-based transcranial direct current stimulation in schizophrenia: Systematic literature review, a teenager case report with cost-utility analysis	46
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	45
Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum	44
Digital health interventions for schizophrenia: Setting standards for mental health	44
Impact of loneliness and living alone on negative symptoms in severe mental illness: An electronic health record data analysis	44
Impact of long-acting injectable antipsychotics in early psychosis: An umbrella review	43
Sex differences and age of onset in well-being and recovery in people with psychotic disorders. A PHAMOUS study	40
Going the extra mile? The influence of Amisulpride on effort-based decisions	40
In this issue	39
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics	39
Editorial Board	36
Epistatic interactions of NRG1 and ERBB4 on antipsychotic treatment response in first-episode schizophrenia patients	36
Identification of ultra-rare missense mutations associated with familial schizophrenia by whole-exome sequencing	35
The role of antipsychotics against COVID-19: A topic for debate	35
Tardive dyskinesia's under-recognition in the era of COVID-19	34
Issue highlights	33

Issue highlights	33
Short-term intake of amisulpride does not alter psychobiological stress responses. A randomized, double-blind, placebo-controlled paradigm using a standardized stressor	32
Understanding the effect of various factors on clozapine serum levels in Indian population	32
The dimensionality of perceptual anomalies and their relationships with bullying victimization among Chinese adolescents: From a network perspective	32
Risk factors for suicidality across psychosis vulnerability spectrum	31
Editorial Board	31
Stem cell transplant in psychotic disorders: Immunological cause or cure?	31
The dilemma of self vs others' interest: Altruistic behaviour in schizophrenia and the role of vasopressin	31